Jump to Navigation

New York Osmoprep Lawyer

Drug Liability Attorneys in New York

Visicol and Osmoprep prescription pills are used for bowel cleansing prior to a colonoscopy. They are sold by Salix Pharmaceuticals. There is a serious risk of the products causing permanent kidney damage.  This occurs through the raising of the phosphate level, dehydration and decreased blood volume.

The New York Osmoprep lawyers of Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP, help people who have been harmed by or lost loved ones due to the use of Visicol and Osmoprep. We are equipped to help you pursue monetary compensation for your medical bills, lost wages and other economic damages.

Contact us today online or by telephone at 888-335-9457 to speak with a knowledgeable New York pharmaceutical litigation lawyer.

The Dangers of Visicol and Osmoprep

At Rheingold, Valet, Rheingold, Shkolnik & McCartney, we have been serving the legal needs of people throughout New York and across the nation for over 30 years. We handle a wide range of complex cases involving drug and medical device liability, including Visicol and Osmoprep.

We allege that the risks of Visicol and Osmoprep were not adequately communicated to users, and that the product exposed users to heightened risk of kidney injuries.

Our attorneys are experienced litigators with a long track record of success, winning settlements and jury awards for our clients. We will work closely with you to determine the full extent of the harm that Visicol or Osmoprep has caused you, in terms of both present-day and future monetary damages. We are happy to answer any questions you may have, and help you explore your legal options.

Contact Us for a Case Evaluation

Have you or someone close to you suffered from the use of Visicol and Osmoprep? Please contact us today online or by telephone at 888-335-9457 to speak with an experienced New York drug liability attorney. Our law office is conveniently located in a brownstone in Midtown Manhattan located at 113 East 37th Street.

For more information, please visit our drugs and medical devices information center.